Longitudinal Study on Diabetic Patients Treated with Detemir Insulin FRESH-PEF8954-en Michel MARRE Longitudinal Study on Diabetic Patients Treated with Detemir Insulin PREDICTIVE: Predictable Results and Experience in Diabetes through Intensification and Control to Target: An International Variability Evaluation FRESH-PEF8954-en 8954 FRESH-PEF8954 Michel MARRE INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) Epidemiology France Portal (PEF) NOVO NORDISK null analogue determir insulin efficacy tolerance Endocrinology Biological determinants: Genetic predisposition Biological determinants To investigate the effect of using determir insulin in normal clinical practice. null Germany Austria Denmark France Ireland United Kingdom Turkey Individuals Patients population Male Female Young Adult (19 to 24 years) Adult (25 to 44 years) Middle Aged (45 to 64 years) Aged (65 to 79 years) Aged, 80 and over (80 years and more) Male and female; - Adult; - Diabetic (type 1 and 2); - Treated with determir insulin. Clinical data Biological data Health event/morbidity Other Through independent healthcare practitioners [1000-10000[ individuals Converting or copying information into a structured record Interview with the participant (including clinical) Observational Study Observational Study 19,911 (Europe): - France (1,772): - 643 patients with type 1 diabetes - 1,129 patients with type 2 diabetes. Unknown Restricted access Contact the principal investigator Access on specific project only